Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers

Fig. 3

Patient with CD of the terminal ileum in treatment with IFX. At baseline, MRI (a and b) detected moderate inflammatory lesions of the terminal ileum, with wall thickening accompanied by oedema, irregularity of the mucosal surface and hyperenhancement after intravenous contrast administration (Overall MaRIA score = 49). Baseline endoscopy of the same segment confirmed the presence of serpiginous, longitudinal ulcerations (c; SES-CD = 20). At week 26, the terminal ileum achieved healing at both MRI (d and e; Overall MaRIA score = 19,2; Δ MaRIA score = 29,8) and endoscopy (f; SES-CD = 0)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us